Skip to main content
Sagar Parikh, MD, Psychiatry, Ann Arbor, MI

SagarV.ParikhMDFRCPC

Psychiatry • Ann Arbor, MI

John F. Greden Professor of Depression and Clinical Neuroscience and Professor of Psychiatry, University of Michigan; Associate Director, University of MIchigan Depression Center; Medical Director, National Network of Depression Centers; Education Chair, Canadian Network for Mood and Anxiety (CANMAT); Professor of Psychiatry, University of Toronto

Join to view full profile

Dr. Parikh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Parikh's full profile

Already have an account?

  • Office

    4250 Plymouth Road
    U of M Psychiatry, Rachel Upjohn Building
    Ann Arbor, MI 48109
    Phone+1 734-232-0241
    Fax+1 734-763-2015
  • Is this information wrong?

Summary

  • Sagar V. Parikh, M.D., FRCPC is appointed as the John F. Greden Professor of Depression and Clinical Neuroscience, and Professor of Psychiatry, at the University of Michigan, Ann Arbor. He is Medical Director of the National Network of Depression Centers (USA) and Education Chair of the Canadian Network of Mood and Anxiety Treatments. He is also a Professor of Health Management and Policy in the School of Public Health at the University of Michigan, and continues as an adjunct Professor of Psychiatry at the University of Toronto, where he was on staff full- time from 1994-2015. Dr. Parikh is the author / editor of three books and over 200 peer-reviewed articles and book chapters, and co-author of all 10 editions (1997-2018) of CANMAT treatment guidelines for Depression and for Bipolar Disorder, the world’s most cited mood disorder guidelines. Current major projects include a multi-site study of Biomarkers in Major Depression, novel medication clinical trials, website and app interventions, Workplace Depression interventions, and interventional psychiatry treatments including IV Ketamine and Transcranial Magnetic Stimulation. As medical director of Mensante, he helped create a novel internet system for recognition and management of mental disorders that is commercially marketed. He serves on the Advisory Board of Aifred (apply Artificial Intelligence tools to psychiatry) and Neonmind (employing psychedelics and developing new clinical models). Dr. Parikh was awarded the Dave Davis CEPD Research Award from the University of Toronto in 2008, the R.O. Jones Award for Best Research Paper by the Canadian Psychiatric Association in 2011, and Paula Goering Collaborative Research and Knowledge Translation Award in 2018. The Michigan Depression Toolkit, a website tool that he leads, won the 2018 Bronze Digital Health Award. He was awarded the 2019 Academic Gold Award for the Psychiatric Services Achievement from the APA, and 2020 Mogens Schou Award from ISBD.

Education & Training

  • Clarke Institute of Psychiatry, University of Toronto
    Clarke Institute of Psychiatry, University of TorontoFellowship, Clinical and Research Fellow in Mood Disorders, 1992 - 1994
  • University of Toronto
    University of TorontoResidency, Psychiatry, 1989 - 1992
  • University of Michigan Health System
    University of Michigan Health SystemResidency, Psychiatry, 1987 - 1988
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1984, M.D., C.M.
  • Columbia University
    Columbia UniversityBS, Bioengineering, 1976 - 1980

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1987 - 2026

Awards, Honors, & Recognition

  • Secretary Secretary of the International Society for Affective Disorders
  • Co-Head, Section of Affective Disorders World Psychiatric Association
  • R.O. Jones Award for Best Research Paper Canadian Psychiatric Association, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Sage Therapeutics and Biogen Announce the Phase 3 CORAL Study Met Its Primary and Key Secondary Endpoints – Comparing Zuranolone 50 Mg Co-Initiated with Standard of Care Antidepressant vs. Standard of Care Co-Initiated with Placebo in People with MDD
    Sage Therapeutics and Biogen Announce the Phase 3 CORAL Study Met Its Primary and Key Secondary Endpoints – Comparing Zuranolone 50 Mg Co-Initiated with Standard of Care Antidepressant vs. Standard of Care Co-Initiated with Placebo in People with MDDFebruary 16th, 2022
  • Psilocybin May Be the Key to Resolving the Global Obesity Epidemic
    Psilocybin May Be the Key to Resolving the Global Obesity EpidemicJuly 28th, 2021
  • Genetic Testing May Help Depressed People Find the Right Medication Faster
    Genetic Testing May Help Depressed People Find the Right Medication FasterFebruary 12th, 2019
  • Join now to see all

Professional Memberships

  • Royal College of Physicians and Surgeons of Canada
    Fellow

Dr. Sagar Parikh, Dr. Sagar Parikh, MD, Dr. S Parikh, Dr. Sagar V. Parikh